{
    "nctId": "NCT02355600",
    "briefTitle": "Oocyte Recovery During Tamoxifen Adjuvant Therapy",
    "officialTitle": "Tamoxifen as Adjuvant Treatment in Breast Cancer and Its Impact on Ovarian Function",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Metaphase II oocytes retrieved",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer patients whose tumors have positive hormone receptors (ER+) subsidiary of adjuvant treatment with tamoxifen\n* Reproductive desire\n\nExclusion Criteria:\n\n* Having received chemotherapy agents less than 12 months ago\n* Current treatment with GnRH analogues\n* Age \\> 35 years old\n* Contraindication for follicular punction or hCG administration",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}